Rb Capital Management, LLC Abbott Laboratories Transaction History

Rb Capital Management, LLC

$407 Million
Q3 2024

A detailed history of Rb Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rb Capital Management, LLC holds 41,183 shares of ABT stock, worth $4.77 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

41,183

Previous 44,266 6.96%

Holding current value

$4.77 Million

Previous $4.6 Million 2.09%

% of portfolio

1.15%

Previous 1.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$100.07 - $118.13 $308,515 - $364,194	-3,083 Reduced 6.96%	41,183 $4.7 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $159,254 - $177,767	-1,581 Reduced 3.45%	44,266 $4.6 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $302,713 - $334,333	-2,764 Reduced 5.69%	45,847 $5.21 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $182,724 - $223,670	-2,026 Reduced 4.0%	48,611 $5.35 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $1,910 - $2,292	-20 Reduced 0.04%	50,637 $4.9 Million
Q2 2023 Dec 11, 2023	BUY	$100.78 - $112.29 $2,015 - $2,245	20 Added 0.04%	50,657 $5.52 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $24,590 - $27,398	244 Added 0.48%	50,657 $5.52 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $159,044 - $187,204	1,642 Added 3.37%	50,413 $5.1 Million
Q4 2022 Jan 10, 2023	BUY	$95.06 - $111.52 $61,218 - $71,818	644 Added 1.34%	48,771 $5.36 Million
Q3 2022 Oct 21, 2022	BUY	$96.76 - $112.03 $150,074 - $173,758	1,551 Added 3.33%	48,127 $4.66 Million
Q2 2022 Jul 14, 2022	BUY	$102.07 - $123.37 $165,251 - $199,736	1,619 Added 3.6%	46,576 $5.06 Million
Q1 2022 Apr 11, 2022	BUY	$114.02 - $139.04 $82,436 - $100,525	723 Added 1.63%	44,957 $5.32 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $993,558 - $1.22 Million	8,600 Added 24.13%	44,234 $6.23 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $55,180 - $61,045	473 Added 1.35%	35,634 $4.21 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $163,233 - $192,149	1,543 Added 4.59%	35,161 $4.08 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $77,602 - $91,427	713 Added 2.17%	33,618 $4.03 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $461,265 - $502,647	4,393 Added 15.41%	32,905 $3.6 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $185,387 - $225,139	2,023 Added 7.64%	28,512 $3.1 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $369,067 - $472,360	4,820 Added 22.24%	26,489 $2.42 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $111,442 - $162,959	1,774 Added 8.92%	21,669 $1.72 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $161,416 - $179,694	2,056 Added 11.53%	19,895 $1.71 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $1.06 Million - $1.15 Million	12,985 Added 267.51%	17,839 $1.45 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $841,399 - $981,325	-11,545 Reduced 70.4%	4,854 $824,000
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $17,548 - $21,215	265 Added 1.64%	16,399 $1.31 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $9,309 - $10,546	-142 Reduced 0.87%	16,134 $1.17 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $7,601 - $9,170	125 Added 0.77%	16,276 $1.19 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $67,126 - $74,087	1,166 Added 7.78%	16,151 $985,000
Q1 2018 Apr 19, 2018	BUY	$56.27 - $63.62 $9,397 - $10,624	167 Added 1.13%	14,985 $898,000
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $453,488 - $485,506	8,448 Added 132.62%	14,818 $846,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $306,142 - $341,686	6,370	6,370 $0

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.

Account

Rb Capital Management, LLC Abbott Laboratories Transaction History